Digitalis-like factor response to hyperinsulinemia in human pregnancy, a model of insulin resistance

Journal of Human Hypertension

Volumn 16, Issue 12, 2002, Pages 851-856

  Seely, E W ^b   Carroll, J A ^b   Goodfriend, T L ^c   Tao, Q F ^b   Graves, S W ^a  

^a Brigham Young University   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Na; K ATPase; Digitalis like factor; Free fatty acids; Glucose tolerance test; Insulin resistance; Pregnancy

Indexed keywords

DIGITALIS LIKE FACTOR; FATTY ACID; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MODEL; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PUERPERIUM; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDENOLIDES; DIGOXIN; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MATERNAL WELFARE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; SAPONINS; STATISTICS; TIME FACTORS; UTAH;

EID: 0036964023     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001497     Document Type: Article

References (30)

1. Modan M et al. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
2. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
3. Carroll JA, Seely EW, Tao Q-F, Graves SW. Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinemic clamp or oral glucose tolerance test. Life Sci 2001; 69: 829-837.
4. Tao Q-F, Soszynski PA, Hollenberg NK, Graves SW. A sensitive [Na, K]ATPase assay, specific for inhibitors acting via the digitalis-binding site. J Cardiovasc Pharmacol 1995; 25: 859-863.
5. Tao Q-F, Soszynski PA, Hollenberg NK, Graves SW. Specificity of the volume-sensitive sodium pump inhibitor isolated from human peritoneal dialysate in chronic renal failure. Kidney Int 1996; 49: 420-429.
6. Krep HH et al. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with Digibind: Stoichiometry and its implications. Am J Hypertens 1995; 9: 39-46.
7. +)ATPase associated with essential hypertension. Nature 1982; 3200: 650-652.
8. Glatter KA et al. Sustained volume expansion and [Na,K]ATPase inhibition in chronic renal failure. Am J Hypertens 1994; 7: 1016-1025.
9. Krep HH et al. Volume sensitive hypertension and the digoxin-like factor: Reversal by an Fab directed against digoxin in DOCA: Salt hypertensive rats. Am J Hypertens 1995; 8: 921-927.
10. Kaide J-I et al. The effects of digoxinspecific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats. Am J Hypertens 1998; 12: 611-619.
11. Chen S et al. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 1993; 6: 397-406.
12. Wasada T et al. Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM. Diabetologia 1995; 38: 792-797.
13. Takahashi H et al. Digoxin-like immunoreactivity may contribute to hyperinsulinemia-associated hypertension in patients with glucose intolerance. J Cardiovasc Pharmacol 1993; 22 (Suppl 2): S22-S24.
14. Martinka E et al. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension. Am J Hypertens 1998; 11: 667-676.
15. Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963; 268: 988-991.
16. Bleicher SJ, O'Sullivan JB, Freinkel N. Carbohydrate metabolism in pregnancy. N Engl J Med 1974; 271: 866-872.
17. Ryan EA, O'Sullivan MJ, Skyler JS. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes 1985; 34: 380-389.
18. 63Ni radiochemical assay of free fatty acids in plasma. Clin Chem 1987; 33: 176-179.
19. Egan BM et al. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension (Part 2): 723-728.
20. Stewart L et al. Vascular smooth muscle response to ouabain: Relation of tissue sodium to the contractile response. Circ Res 1993; 73: 1113-1120.
21. Hubel CA et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increase in preeclampsia, are positively correlated, and decrease within 48 h postpartum. Am J Obstet Gynecol 1996; 174: 975-982.
22. Solomon CA et al. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 1999; 12: 276-282.
23. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16: 41-66.
24. Graves SW, Williams GH. An endogenous ouabain-like factor associated with hypertensive pregnancies. J Clin Endocrinol Metab 1984; 59: 1070-1074.
25. Seely EW, Williams GH, Graves SW. Markers of sodium and volume homeostasis in pregnancy-induced hypertension. J Clin Endocrinol Metab 1992; 74: 150-156.
26. Martinka E et al. Digoxin-like immunoactivity and glucose intolerance in pregnancy. Diab Nutr Metab 1993; 6: 189-194.
27. Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med 1988; 318: 518-519.
28. Adair CD et al. Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: Treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16: 529-531.
29. Kelly RA, O'Hara DS, Mitch WE, Smith TW. Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem 1986; 261: 11704-11711.
30. Solomon CG, Graves SW, Greene MF, Seely EW. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994; 23: 717-721.